The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders.
The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders.
复制标题
DOI:
10.1002/mds.29182
复制
发表时间:
2022-11
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
The objective of this study was to better delineate the genetic landscape and key clinical characteristics of complex, early‐onset, monogenic hyperkinetic movement disorders. Patients were recruited from 14 international centers. Participating clinicians completed standardized proformas capturing demographic, clinical, and genetic data. Two pediatric movement disorder experts reviewed available video footage, classifying hyperkinetic movements according to published criteria. One hundred forty patients with pathogenic variants in 17 different genes (ADCY5, ATP1A3, DDC, DHPR, FOXG1, GCH1, GNAO1, KMT2B, MICU1, NKX2.1, PDE10A, PTPS, SGCE, SLC2A1, SLC6A3, SPR, and TH) were identified. In the majority, hyperkinetic movements were generalized (77%), with most patients (69%) manifesting combined motor semiologies. Parkinsonism‐dystonia was characteristic of primary neurotransmitter disorders (DDC, DHPR, PTPS, SLC6A3, SPR, TH); chorea predominated in ADCY5‐, ATP1A3‐, FOXG1‐, NKX2.1‐, SLC2A1‐, GNAO1‐, and PDE10A‐related disorders; and stereotypies were a prominent feature in FOXG1‐ and GNAO1‐related disease. Those with generalized hyperkinetic movements had an earlier disease onset than those with focal/segmental distribution (2.5 ± 0.3 vs. 4.7 ± 0.7 years; P = 0.007). Patients with developmental delay also presented with hyperkinetic movements earlier than those with normal neurodevelopment (1.5 ± 2.9 vs. 4.7 ± 3.8 years; P < 0.001). Effective disease‐specific therapies included dopaminergic agents for neurotransmitters disorders, ketogenic diet for glucose transporter deficiency, and deep brain stimulation for SGCE‐, KMT2B‐, and GNAO1‐related hyperkinesia. This study highlights the complex phenotypes observed in children with genetic hyperkinetic movement disorders that can lead to diagnostic difficulty. We provide a comprehensive analysis of motor semiology to guide physicians in the genetic investigation of these patients, to facilitate early diagnosis, precision medicine treatments, and genetic counseling. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society
登录
查看更多内容
影响因子:
5.1
作者:
Gatto, Emilia M.;Walker, Ruth H.;Jinnah, Hyder A.
通讯作者:
Jinnah, Hyder A.
影响因子:
9.9
作者:
Leuzzi, V;Carducci, C;Antonozzi, I
通讯作者:
Antonozzi, I
影响因子:
9.9
作者:
Papandreou A;Schneider RB;Augustine EF;Ng J;Mankad K;Meyer E;McTague A;Ngoh A;Hemingway C;Robinson R;Varadkar SM;Kinali M;Salpietro V;O'Driscoll MC;Basheer SN;Webster RI;Mohammad SS;Pula S;McGowan M;Trump N;Jenkins L;Elmslie F;Scott RH;Hurst JA;Perez-Duenas B;Paciorkowski AR;Kurian MA
通讯作者:
Kurian MA
影响因子:
36.4
作者:
Chien, Yin-Hsiu;Lee, Ni-Chung;Hwu, Wuh-Liang
通讯作者:
Hwu, Wuh-Liang
DOI:
10.1111/j.1469-8749.2012.04287.x
发表时间:
2012-07-01
影响因子:
3.8
作者:
Dale, Russell C.;Grattan-Smith, Padraic;Peters, Greg B.
通讯作者:
Peters, Greg B.